Korea Investment CORP increased its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 131.1% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 45,826 shares of the medical instruments supplier’s stock after acquiring an additional 26,000 shares during the period. Korea Investment CORP’s holdings in DENTSPLY SIRONA were worth $2,006,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Piedmont Investment Advisors LLC acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $117,000. Cornerstone Wealth Management LLC acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $202,000. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $209,000. IBM Retirement Fund grew its position in shares of DENTSPLY SIRONA by 49.1% during the 1st quarter. IBM Retirement Fund now owns 4,955 shares of the medical instruments supplier’s stock valued at $249,000 after acquiring an additional 1,631 shares during the period. Finally, Northwest Investment Counselors LLC grew its position in shares of DENTSPLY SIRONA by 21.0% during the 2nd quarter. Northwest Investment Counselors LLC now owns 7,582 shares of the medical instruments supplier’s stock valued at $332,000 after acquiring an additional 1,318 shares during the period. Hedge funds and other institutional investors own 97.65% of the company’s stock.

XRAY stock opened at $38.42 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.10 and a current ratio of 1.69. DENTSPLY SIRONA Inc has a 12-month low of $37.46 and a 12-month high of $68.98. The stock has a market capitalization of $8.62 billion, a P/E ratio of 14.44, a PEG ratio of 2.24 and a beta of 1.20.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Tuesday, August 7th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.59 by $0.01. DENTSPLY SIRONA had a positive return on equity of 9.12% and a negative net margin of 39.62%. The company had revenue of $1.04 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the previous year, the firm posted $0.65 EPS. analysts expect that DENTSPLY SIRONA Inc will post 2.08 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 12th. Investors of record on Friday, September 28th will be issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend is Thursday, September 27th. DENTSPLY SIRONA’s payout ratio is 13.16%.

A number of research firms have recently commented on XRAY. HC Wainwright set a $40.00 target price on DENTSPLY SIRONA and gave the company a “hold” rating in a research report on Friday, August 31st. Robert W. Baird cut DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and dropped their target price for the company from $56.00 to $38.00 in a research report on Tuesday, August 7th. BidaskClub upgraded DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Friday, July 6th. Stifel Nicolaus dropped their target price on DENTSPLY SIRONA from $57.00 to $46.00 and set a “buy” rating on the stock in a research report on Wednesday, August 8th. Finally, Morgan Stanley cut DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and lowered their price objective for the stock from $54.00 to $40.00 in a report on Wednesday, August 8th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $52.18.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Read More: Diversification

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.